What is the trade name for Flibanserin?

Trade Name for Flibanserin

The trade name for flibanserin is Addyi®. 1

Key Product Information

• Addyi® (flibanserin) tablets are available as 100 mg oral tablets for once-daily administration at bedtime 1

• The medication received FDA approval in August 2015 for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women 2, 3

Clinical Context

• Flibanserin is a 5-HT1A agonist and 5-HT2A antagonist that works by modulating neurotransmitter levels affecting sexual desire 4

• The medication demonstrates modest efficacy, resulting in approximately 1 additional satisfying sexual event every 2 months compared to placebo 2, 5, 3

• Pharmacists must dispense Addyi® in its original packaging and provide the accompanying Medication Guide to each patient 1

Important Prescribing Considerations

• The standard dosing is flibanserin 100 mg once daily at bedtime 2, 5

• Common adverse effects include dizziness and somnolence, which are typical of centrally acting medications 2, 4

• The medication has not been studied in women with a history of cancer or those on endocrine therapy 5